Accustem Sciences (ACUT) Current Assets (2021 - 2026)
Accustem Sciences (ACUT) posted quarterly Current Assets of $49532.0 for Q1 2026, down 96.81% year-over-year from $1.6 million in Q1 2025, and little changed quarter-over-quarter from $49446.0 in Q4 2025.
Accustem Sciences (ACUT) Current Assets (2021 - 2026) Analysis & Trends
Accustem Sciences (ACUT) has reported Current Assets for 6 consecutive years, with $49532.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Current Assets fell 96.81% year-over-year to $49532.0; the TTM figure through Mar 2026 stood at $49532.0 (down 96.81% YoY), while the FY2025 annual figure was $49446.0, down 1.96% from the prior year.
- Current Assets held at $49532.0 in Q1 2026 per ACUT's latest filing, from $49446.0 in the prior quarter.
- Across five years, Current Assets topped out at $3.2 million in Q1 2022 and bottomed at $47801.0 in Q1 2024.
- Historically, Current Assets has averaged $847851.1 across 5 years, with a median of $252620.0 in 2023.
- Annual changes were most pronounced in 2025 — Current Assets surged 3143.61% — and 2026, when it slumped 96.81%.
- Accustem Sciences' Current Assets stood at $932011.0 in 2022, then slumped by 86.07% to $129849.0 in 2023, then slumped by 61.16% to $50433.0 in 2024, then slipped by 1.96% to $49446.0 in 2025, then grew by 0.17% to $49532.0 in 2026.
- Business Quant data shows ACUT's Current Assets at $49532.0 in Q1 2026, $49446.0 in Q4 2025, and $1.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 12.54 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 18.45 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 8.07 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 5.82 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 7.22 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 4.62 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 18.80 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 1.63 Bn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 1.76 Bn |
| 10 | Accustem Sciences | 2.57 Mn | 2.56 Mn | - | 106,204.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 49,532.00 |
| Dec 31, 2025 | 49,446.00 |
| Sep 30, 2025 | 1.57 Mn |
| Jun 30, 2025 | 1.61 Mn |
| Mar 31, 2025 | 1.55 Mn |
| Dec 31, 2024 | 50,433.00 |
| Sep 30, 2024 | 102,494.00 |
| Jun 30, 2024 | 137,427.00 |
| Mar 31, 2024 | 47,801.00 |
| Dec 31, 2023 | 129,849.00 |
| Sep 30, 2023 | 252,620.00 |
| Jun 30, 2023 | 452,667.00 |
| Mar 31, 2023 | 240,789.00 |
| Dec 31, 2022 | 932,011.00 |
| Sep 30, 2022 | 1.61 Mn |
| Jun 30, 2022 | 2.37 Mn |
| Mar 31, 2022 | 3.24 Mn |
| Dec 31, 2021 | 1.35 Mn |